| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |